---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Toripalimab-tpzi - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/toripalimab-tpzi
version: v1
---

# Toripalimab-tpzi - NCI

# Toripalimab-tpzi

Placeholder slot

(TOR-ih-PA-lih-mab)

This page contains brief information about toripalimab-tpzi
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Loqtorzi

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06851535-9c74-6d6d-e063-6294a90abc76&audience=consumer)

## Use in Cancer

Toripalimab-tpzi
is approved to treat:

- [Nasopharyngeal carcinoma](/Common/PopUps/popDefinition.aspx?id=445072&version=Patient&language=English) (a type of [head and neck cancer](/Common/PopUps/popDefinition.aspx?id=257519&version=Patient&language=English)). It is used:
- With [cisplatin](/Common/PopUps/popDefinition.aspx?id=45230&version=Patient&language=English) and [gemcitabine hydrochloride](/Common/PopUps/popDefinition.aspx?id=508951&version=Patient&language=English) as the first treatment in adults whose cancer has spread to other parts of the body or has come back in nearby tissues.
- Alone in adults whose cancer has come back and cannot be removed by surgery or has spread to other parts of the body and has been treated with [platinum](/Common/PopUps/popDefinition.aspx?id=45841&version=Patient&language=English) chemotherapy that did not work or is no longer working.

Toripalimab-tpzi
is also being studied in the treatment of other types of
cancer.

## More About Toripalimab-tpzi

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785704) - Detailed scientific definition and other names for this drug.

## Research Results and Related Resources

[Toripalimab Becomes First Immunotherapy Drug Approved for Nasopharyngeal Cancer](https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-toripalimab-nasopharyngeal-cancer)

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Monoclonal Antibodies](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies)

[Immune Checkpoint Inhibitors](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Toripalimab-tpzi](https://www.cancer.gov/research/participate/clinical-trials/intervention/C131334) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
